VUMC Limited Submission Opportunity: Mary Kay Foundation Translational Cancer Research Grant; deadline is Dec. 5
These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.
Applications due December 5
Vanderbilt University Medical Center (VUMC) has been invited to nominate one candidate for the Mary Kay Foundation Translational Cancer Research Grant program for 2020. These awards provide $100,000 over two years to support translational research in ovarian, uterine, breast, or cervical cancer.
The Mary Kay Foundation seeks to fund innovative research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in the diagnosis, prognosis, prevention, or treatment of cancer.
You can find a list of the previous award recipients here.
Considerations:
- Principal Investigator must be Full-time Assistant Professor or higher (Assistant, Associate, or Full Professor)
- Staff scientists, postdoctoral trainees and instructors are NOT eligible
- Maximum $100,000 award includes direct and indirect costs over a two-year period. (Indirects may not exceed 15%).
- U.S. citizenship is not required.
Internal Application Process:
Anyone interested in being considered as VUMC’s nominee must submit the following to LSO@vanderbilt.edu by 5 p.m. on December 5, 2019. Please combine your materials into a single PDF and reference the program name in the subject line of the email.
- Brief research plan including summary budget (2 page max including budget);
- Statement of support from department chair/center director;
- NIH Biosketch
The chosen nominee will submit a full proposal to the Foundation by the deadline of February 7, 2020.
Direct all questions about the application process to LSO@vanderbilt.edu.